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the demand for animal protein for human consumption has been risen exponentially. Modern animal 
production practices are associated with the regular use of antibiotics, potentially increasing the 
emerging multi-resistant bacteria, which may have a negative impact on public health. in poultry 
production, substances capable of maximizing the animals’ performance and displaying an antimicrobial 
activity against pathogens are very well desirable features. Probiotic can be an efficient solution for such 
a task. in the present work, lactic acid bacteria (LAB) were isolated from chicken cecum and screened for 
their antagonistic effect towards many pathogens. Their capacity of producing the B-complex vitamins 
folate and riboflavin were also evaluated. From 314 isolates, three (C43, C175 and C195) produced 
Bacteriocin-Like inhibitory Substances (BLiS) against Staphylococcus aureus (inhibition zones of 18.9, 
21.5, 19.5 mm, respectively) and also inhibited the growth of Salmonella Heidelberg. The isolate C43 was 
identified as Enterococcus faecium, while C173 and C195 were both identified as Lactococcus lactis subsp. 
lactis. Moreover, the isolates L. lactis subsp. lactis strains C173 and C195 demonstrated high potential to 
be used as probiotic in poultry feed, in addition to their advantage of producing folate (58.0 and 595.5 ng/
mL, respectively) and riboflavin (223.3 and 175.0 ng/mL, respectively).
The use of antibiotics in animal production originated more than 70 years ago, when chlortetracycline was shown 
to improve the growth and health of chicks1. Since then, antibiotics have not only been widely used in the treat-
ment and prevention of diseases, but also to improve animal growth and productivity2. Their use in farming ani-
mals to increase profits and their correlation with antimicrobial resistance in humans is a polemic subject since 
some antibiotics used in animals are the same or are closely related to the antibiotics used in human therapeutics3.
Even though the use of antibiotics in veterinary medicine is used cautiously and is well controlled by national 
and international organizations, many studies have recognized that using antibiotics in farming animals may 
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have a negative impact on public health4. This impact may be related to the selection of resistant microorganisms, 
zoonotic transmission or transference of resistance genes between animal and human bacteria5.
The first evidence of this correlation was reported in 1995, when after banning avoparcin, which is chemically 
related to the glycopeptide vancomycin commonly used as a growth promoter for broilers, there was a reduction 
in the prevalence of vancomycin-resistant enterococci (VRE) from 72% in 1995 to 2% in 20056. An equivalent 
decline in prevalence of E. faecium resistant to avilamycin was observed after the prohibition of this antibiotic6.
In Denmark, the prevalence of VRE in pigs persisted for three years after the ban of avoparcin, until the 
growth promoter tylosin (a macrolide) was also prohibited. The genetic characterization of VRE isolated from 
these animals revealed the presence of plasmids encoding resistance to glycopeptides and macrolides, suggesting 
that the resistance to vancomycin could have been a consequence of using tylosin after the avoparcin prohibition7.
Brazil is the second largest producer and largest exporter of poultry meat in the world, with poultry products 
traded in more than 150 countries. Data from the Brazilian Association of Animal Protein, for the year 2017, 
recorded the production of 13,056 million tons of chicken meat, with exportation of 4,320 million tons8.
Salmonella Heidelberg is one of the emerging serogroups in Brazil and there is a concern in the poultry sec-
tor because this pathogenic microorganism is multiresistant and carries molecular determinants of beta-lactam 
resistance9. For many decades, the Poultry Health Program has used strategies focused on controlling Salmonella 
Gallinarum, Salmonella Pullorum, Salmonella Typhimurium and Salmonella Enteritidis10. The prevalence of 
these serovars has been well controlled, but there is a difficulty in controlling the avian paratyphoid, especially in 
Heidelberg and Minesota serovars.
Recently, in Brazil, it has been identified between a 5% and 11% positive result for non-typhoidal Salmonella 
in avian origin samples, where Salmonella Heidelberg and S. Typhimurium have been the most common11–14. 
Moreover, in United States, S. Heidelberg is currently the 12th most common serovar of Salmonella enterica caus-
ing salmonellosis and results in twice the average incidence of blood infections caused by non-typhoidal salmo-
nellae. Several outbreaks of salmonellosis caused by S. Heidelberg resulted from the poultry processing15.
Increasing evidences led the World Health Organization suggest the phase out or even the complete ban of 
antibiotic growth promoters (AGPs)16–18. The European Commission banned the marketing and use of AGPs in 
feed nutrition since 200619. In the United States, the use of fluoroquinolones in poultry was banned in 2005. After 
that, the number of fluoroquinolone-resistant Campylobacter infections in humans has significantly decreased20. 
Such phasing-out of AGPs increased the pressure of the livestock industry to search for viable alternatives that can 
improve the natural defense mechanism of these animals21,22. In this sense, the use of probiotic microorganisms 
has gained much attention.
Probiotics are defined as: “living microorganisms which, when administered in adequate quantities, confer 
benefits to the host’s health”23. When used as a feed additive these microorganisms are associated with maintain-
ing a balanced intestinal microbiota, increasing the resistance against pathogenic bacteria and improving the 
immunity of the host24. Such benefits by probiotic strains can be due to their capability of producing fatty acids 
and organic acids, as well as the synthesis of compounds such as vitamins and antimicrobial biomolecules like 
bacteriocins, also named as bacteriocin-like inhibitory substance (BLIS), which act specifically against certain 
pathogens or in the activity of certain enzymes23. The BLIS nomenclature was proposed by Tagg, Dajani and 
Wannamaker25 and is recommended when a newly discovered bacteriocin is not completely characterized regard-
ing its amino acid or nucleotide sequences.
Probiotic strains should not compete with the microorganisms of the normal microbiota, instead they should 
interact in symbiosis. Moreover, they must be resistant to bile and acids from the gastrointestinal tract and have 
the ability to adhere to the intestinal mucosa cells, rapidly multiplying in order to always be present in the intes-
tinal lumen and not be completely eliminated during intestinal peristalsis. Another fundamental criterion is 
the safety for use in humans or animals26. Probiotic microorganisms usually used in food, pharmaceutical and 
veterinary industries belong to the Lactic Acid Bacteria (LAB) group since these have being historically used in 
the manufacture of dairy foods and as starter cultures and have received the “generally regarded as safe” (GRAS) 
status from the US Food and Drug Administration27.
It should be emphasized that during animal management, several stressful situations can affect their growth 
and health28. Although breeders provide balanced diets, clinical or subclinical deficiencies of some essential vita-
mins for proper animal development may occur, which can significantly affect production costs29. Although LAB 
are usually known as auxotrophic for some vitamins, certain strains have the ability to synthesize water soluble 
vitamins, including those comprising the B group30. In poultry nutrition, B-complex vitamins such as folates and 
riboflavin are essential as evidenced by diverse symptoms when they are deficient31.
As mentioned above, the production of antimicrobial substances by probiotic strains, such as bacteriocins, 
makes the use of these microorganisms additionally advantageous. Although several microorganisms can pro-
duce bacteriocins, those produced by LAB have gained importance due to their potential use as biopreservatives 
for foods32. By definition, bacteriocins are peptides or proteins synthesized via the ribosome and exported to the 
extracellular medium which, in turn, have antimicrobial activity against other closely related bacterial species33. 
Inhibition of pathogenic bacteria by LAB is mediated mainly by the production of these biomolecules, which 
stimulate animal productivity, providing weight gain, strengthening the immune system and reducing the mor-
tality rate by controlling pathogens that commonly affect pigs, cattle and birds34–37.
In poultry production, one of the main goals is the reduction, through the introduction of probiotic bacteria 
in their diets, of the foodborne pathogens Salmonella ssp. and Campylobacter ssp38,39. These pathogenic micro-
organisms are the major cause of diseases in humans transmitted by contaminated foods, with birds being an 
important reservoir, when contaminated by such pathogen39,40.
Based on all of the above, the aim of this study was to isolate potential probiotic LAB from chicken cecum 
content capable of producing antimicrobial activity against Salmonella Heidelberg, and produce the B-complex 
vitamins riboflavin and folate.
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Materials and methods
Sampling of chicken cecum and LAB isolation. The screening for interesting LAB was conducted based 
on the protocol described by Messaoudi et al.41. Broiler chickens (Gallus gallus domesticus) in our study were 
fed with animal protein and AGP-free commercial feed and water ad libitum. They were maintained under con-
trolled management conditions (diet, room temperature, cleaning). When animals reached 12-weeks of age, they 
were sacrificed with an anesthetic overdose (barbiturate). The cecum was carefully removed from the carcasses 
under aseptic conditions and transported to the laboratory in a refrigerated thermal box (~4 °C). Inside a laminar 
airflow biological cabinet, 10 g of it was transferred to a sterile plastic bag containing 90 mL of 0.1% (w/v) bacte-
riological peptone water (Sigma-Aldrich, Missouri, USA). It was homogenized for 2 min in a Stomacher device 
(SPlabor, São Paulo, Brazil), and the resulting product was serially diluted in sterile 0.85% (w/v) NaCl solution. 
One hundred μL of each dilution was transferred to Petri dishes (90 × 15 mm) containing Man, Rogosa and 
Sharpe (MRS) agar medium (Difco, Michigan, USA), Bifidus Selective Medium (BSM) agar (Sigma-Aldrich), 
and M17 agar medium (Difco, Michigan, USA) supplemented with 0.1 g/L of cycloheximide (Inlab, São Paulo, 
Brazil), as selective culture media for Lactobacillus, Bifidobacterium, Lactococcus genus, respectively. Using a ster-
ile Drigalski handle, the dilutions were spread over the surface of the agar medium plates and, anaerobically 
incubated for 48 h at 30, 37, or 45 °C in a microaerophilic jar using a GasPak EZ Container System (BD Diagnostic 
Systems, Maryland, USA) to ensure hypoxia. After this period 314 colonies showing different morphologies were 
randomly selected and subcultured onto the aforementioned agar media plates, which were used in the following 
steps.
This study The study was approved by Ethics Committee on the use of animals of School of Veterinary 
Medicine and Animal Science in the University of São Paulo (registration number 7843030717). All experiments 
were performed in accordance with relevant guidelines and regulations.
Screening for LAB with antimicrobial activity against S. Heidelberg. S. Heidelberg strains IOC 
969/17, isolated from chicken carcass sample was provided by FioCruz (Rio de Janeiro, RJ, Brazil) and used as 
bioindicator strain to evaluate the antimicrobial activity of the 314 isolates. The bioindicator strain was cultured 
in Brain Heart Infusion (BHI; Difco, Michigan, USA) broth for 18 h at 37 °C and 100-fold diluted (to approxi-
mately 106 CFU/mL). This suspension was used to inoculate BHI soft agar (0.75% [w/v] of agar) at 1/10 ratio 
(v/v) and the resulting mixture was used to overlay the agar media plates containing the 314 isolates. The plates 
were incubated at 37 °C for 24 h. Isolates showing the largest inhibition zones against S. Heidelberg IOC 969/17 
were selected and subcultured in the appropriated medium (BHI, M17 or BSM) and temperature (30, 37 or 
42 °C), according to the isolates preferences. They were first characterized morphologically by microscopy, 
Gram staining, and the detection of catalase activity. Gram-positive, catalase negative isolates were considered 
as potential LAB and used in further studies. All the isolates were stored at −70 °C using 20% (v/v) glycerol as 
cryopreservative.
evaluating the nature of the antimicrobial activity. To evaluation of the nature of the antimicrobial 
activity demonstrated by the selected isolates against S. Heidelberg IOC 969/17 was performed using previously 
established protocols42. The isolates were cultured in their preferential media broth and temperature for 24 h, 
then centrifuged (Boeco, Hamburg, Germany) at 12,000 g at 4 °C for 15 min. From each culture broth, the super-
natant was recovered and the pH adjusted to 6.0 – 6.5 with 1.0 M NaOH. The samples were filtered through 
0.22-μm hydrophilic PVDF membranes (Millipore, Maryland, USA), resulting in cell-free supernatants labeled 
as CFS-A. Then, these CFS-A samples were investigated regarding their antimicrobial effect against S. Heidelberg 
IOC 969/17.
The potential inhibitory effect of CFS-A samples against S. Heidelberg IOC 969/17 was investigated by the 
agar diffusion method, specifically spot-on-the-lawn methodology42. For that, the bioindicator strain was precul-
tivated at 37 °C in BHI broth and after 18 h it was 100-fold diluted (approximately 106 CFU/mL) and 1 mL of this 
suspension was transferred to a Petri dish (90 × 15 mm) containing 9 mL of BHI melted soft agar (supplemented 
with 0.75% [w/v] of agar). After solidification, 20 μL of each CFS-A was pipetted onto the agar surface and, finally, 
the plates were incubated at 37 °C for 24 h. The inhibition zone formed after such period by the CFS-A was meas-
ured using a digital caliper and the antimicrobial activity was associated with BLIS production.
Additionally, attempting to verify the inhibitory spectrum caused by BLIS present in the CFS-A, the samples 
were also tested against other bioindicator strains, such as Listeria monocytogenes CECT-934, Salmonella enterica 
CECT-724, S. aureus CECT-237, Escherichia coli ATCC 25922, Carnobacterium piscicola CECT-4020, Listeria 
innocua CLIST 2052. All strains were cultured under conditions similar to S. Heidelberg IOC 969/17, except for 
C. piscicola CECT-4020, which was cultured in MRS broth. The antimicrobial activity was determined in techni-
cal triplicate.
To see if BLIS were of proteinic nature CFS-A samples which exhibited inhibition zones against the bioindi-
cator strains were treated with 3 mg/mL (w/v) of the proteolytic enzyme protease XIV (Sigma-Aldrich, Missouri, 
USA) which was added to 1 mL of each CFS-A and incubated at 30 °C for 2 h42. After that, the solutions were 
evaluated regarding their remaining antimicrobial activity against S. aureus CECT-237, following the protocol 
described above. The solutions demonstrating no inhibition zones were considered, in this study, as being BLIS.
The isolates producing CFS-A with antimicrobial activity against most bioindicator strains were cultured and 
after 24 h incubation the supernatants were once again recovered. At this time, the aim was to investigate the anti-
microbial activity of the organic acids supposedly produced against S. Heidelberg IOC 969/17, so no pH adjust-
ment were performed, resulting in CFS-B samples. To carry out this assay, the bioindicator strain was cultured 
in 10 mL of BHI broth at 37 °C for 24 h and diluted in 2× BHI broth to achieve a cell concentration of 0.2 optical 
density (OD) units at 600 nm per milliliter. After that, 100 μL of this solution was placed into wells of a 96-well 
sterile covered microplates (TPP, Trasadingen, Switzerland) together with 100 μL of each CFS-B sample from the 
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selected isolates Finally, the microplate was covered and incubated on a microplate reader (Bioteck Instruments, 
Vermont, USA) at 37 °C, where OD was recorded every 1 h at 600 nm for 24 h.
Identification of LAB producing B-complex vitamins. The isolates, which displayed the largest inhi-
bition zones against most of bioindicator strain, were selected to evaluate their ability to produce the B-complex 
vitamins riboflavin and folate. The protocol was followed according to Laiño et al.43. Briefly, the selected isolates, 
stored at −70 °C, were first activated in the above-mentioned medium and conditions, according to the isolates 
preferences. After 24 h incubation, 1 mL-aliquots were centrifugated at 12,000 g at 4 °C for 15 min. The superna-
tants were discarded and the pellet cells were washed 3 times with sterile 0.85% (w/v) saline, being resuspended 
at the original culture volume after this 3-washes steps. The resulted solutions were used to inoculate at 2% (v/v) 
the Folic Acid Casei Medium (FACM; Himedia, Mumbai, India), and the Riboflavin Assay Medium (RAM; Difco, 
Maryland, USA), which are free from folates and riboflavin, respectively. The cultures were incubated without 
agitation at 37 °C for 18 h and after growth those 3-washes and resuspending step was repeated. The resulting 
solutions were used to inoculate at 2% (v/v) fresh FACM or RAM. In order to deplete the reserves of folates or 
riboflavin from the isolates, this last step was repeated 7 times with the cultures showing good growth (observed 
by increased turbidity). The isolates which did not grow in FACM or RAM were not used in further studies.
Folate quantification. A 500 μL sample of isolates grown in FACM were taken and diluted with same volume 
of protecting buffer (0.1 mol/L phosphate buffer, pH 6.8, containing 1.5% [w/v] ascorbic acid to prevent vitamin 
oxidation and degradation) followed by immediate centrifugation at 12,000 g at 4 °C for 5 min. The obtained 
supernatants were then boiled (100 °C) for 5 min and stored at –70 °C until folate quantification.
Folate quantification was determined by a microbiological assay using Lactobacillus casei subsp. rhamnosus 
ATCC 7469, provided by Fiocruz (Rio de Janeiro, RJ, Brazil) as the indicator strain according to Horne and 
Petterson44. The strain was previously cultured in MRS broth at 37 °C for 24 h and cryopreserved using 20% (v/v) 
glycerol and stored at –70 °C. Fresh MRS broth was used to activate the strain under the same mentioned condi-
tions. After growth, 1mL-aliquot was washed 3 times with sterile 0.85% (w/v) saline, resuspended in the original 
volume, and used to inoculate at 2% (v/v) fresh FACM, which was incubated for 24 h at 37 °C. This last step was 
repeated and the second culture was used to perform the folate determination, as follows bellow.
The frozen samples were thawed at room temperature (24 °C) and processed in light-reduced conditions45. 
The samples were then diluted with protection buffer and 100 μL of each sample was placed into wells of a 96-well 
sterile covered microplates (TPP, Trasadingen, Switzerland). The folate concentration of each diluted sample was 
determined in triplicate. One hundred microliters of the indicator strain L. casei subsp. rhamnosus ATCC 7469, 
grown in FACM as described above, was added to each well and mixed. The growth in the presence of the samples 
was compared to those with a standard curve prepared using HPLC grade folic acid (Sigma-Aldrich, Missouri, 
USA) diluted in the protection buffer at different concentrations (between 0 and 0.1 ng/mL).
Riboflavin determination. The determination of riboflavin was carried out according to de Arruda et al.46 with 
some adaptations. Briefly, the selected isolates were cultured following above-described conditions. After 24 h 
incubation, using a 100 mL-Erlenmeyer flasks, 5 mL of each culture broths were added with 45 mL of 0.1 M hydro-
chloric acid. The resulting solutions were heated in a shaking thermoregulated bath at 100 °C/100 rpm for 30 min. 
The solutions were cooled to room temperature (24 °C) and had their pH adjusted to 4.6 using 2.5 M sodium 
acetate. After adding 0.5 g of the enzyme diastase from Aspergillus oryzae (Merck Millipore, Massachusetts, USA), 
the solutions were incubated for 2 h at 42 °C in a thermoregulated bath. After such enzymatic treatment and 
cooling at room temperature (24 °C), the solutions were transferred to 100 mL-volumetric flasks and the volumes 
were completed with deionized water, homogenized and filtered through 0.45-μm hydrophilic PVDF membranes 
(Nova Analítica, São Paulo, Brazil) for injection into the chromatographic system. This step was carried out in 
triplicate.
The chromatography system was equipped with two Shimadzu (LC-20AT) pumps, Shimadzu (SIL-20A 
Autosampler) autosampler; Shimadzu (RF-10AXL) Fluorescence detector; Software LC-Solution, Shimadzu 
CBM-20A (SCL-10AVP) system. The method to quantify riboflavin concentration of each sample was accord-
ing to de Arruda et al.46. Twenty μL of samples solutions was injected into column C18 reversed-phase (RP-18 
spherical 5 mm/250 mm 4.6 Shimadzu1 Shim-pack, P/N 228- 34937-92) with pre-column (5 mm/10 mm 4.6 mm 
Shimadzu1 Shim-pack, VP-ODS P/N 228-34938-91). The mobile phase was composed of phosphate buffer pH 
7.2 (10 mM KH2PO4·3H2O) and dimethylformamide (85:15); flow: 1 mL/min; detected by fluorescence: Ex 
450 nm; Em 530 nm.
Identification of the selected LAB isolates using matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOFMS). To identify the selected isolates, MALDI-TOFMS 
analysis were adopted according to Alves et al.47. They were cultured in plates containing MRS or BSM 1.5% 
agar and after 24 h incubation under anaerobic condition, the isolates were transferred from the plates to a 1.5 
mL-microtube containing 200 μL of distilled water and homogenized during 1 min in a vortex device. Then, 
900 μL of ethanol was added and the samples were centrifuged at 12,000 g at 4 °C for 5 min. The supernatant was 
discharged, and the residual alcohol was left to dry at room temperature. The resulting pellet was suspended in 
50 μL of 70% formic acid and 50 μL of acetonitrile was added, and the sample was homogenized using a vortex. 
An α-cyano-4-hydroxycinnamic acid matrix was prepared as a saturated solution in 50% acetonitrile and 2.5% 
trifluoroacetic acid. Subsequently, 1 μL of samples previously treated and 1 μL of matrix solution was spotted onto 
a steel target plate and allowed to dry at room temperature.
The mass spectrometry analyses were conducted using an UltrafleXtreme MALDI-TOF mass spectrometer 
(Bruker Daltonics, Germany) operating in the linear positive ion mode. Mass spectra were acquired in a mass 
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range from 2 to 20 kDa with ions formed by irradiation of smart beam using a frequency of 2000 Hz, PIE 100 ns, 
7 kV lens. The voltages for the first and second ion sources were 25 kV and 23 kV, respectively. Bacteria were iden-
tified by means of the Biotyper 3.1 database. The identification cut-off values higher than 2 and 1.7 were used for 
species and genus identification, respectively.
In vitro evaluation of desirable criteria to consider the selected isolates as probiotic LAB. 
Tolerance to low pH. To verify the isolates’ tolerance to low pH conditions, it was adopted the protocol devel-
oped by Zoumpopoulou et al.48 and Argyri et al.49. Briefly, the isolates were cultured in the preferential medium 
and temperature. After 18 h incubation, the culture broths were centrifugated at 4,470 g at 4 °C for 10 min and the 
pellets cells were washed twice with phosphate buffered saline (PBS) (pH 7.2) before being resuspended in PBS 
solution adjusted to pH 2.5. To reflect the time spent by food in the stomach, the resulting solutions were incu-
bated at 37 °C for 0, 0.5, 1.0, 2.0 and 3.0 h and the tolerance was observed in triplicate in terms of viable colony 
counts and enumerated on the same medium initially used to cultivate the isolates added with 1.5% (w/v) agar.
Tolerance to bile salts. The tolerance to bile salts was evaluated adapting the protocol followed by Maragkoudakis 
et al.50 and Pedersen et al.51. The isolates were cultured in MRS broth at 37 °C for 24 h. After that, 1 mL of such 
cultures broths were used to inoculate, individually, 9 mL of MRS broth supplemented with 0.5% (w/v) porcine 
bile extract (Sigma-Aldrich, Missouri, USA). The resulting solutions were incubated at 37 °C for 4 h. The isolates 
demonstrating bile resistance were assessed in terms of viable colony counts, enumerated after incubation for 0, 
1, 2, 3 and 4 h, which the latter being representative of the time spent by food in the small intestine.
Hemolytic activity. In order to investigate if the isolates produced hemolytic activity, they were cultured in the 
appropriated conditions mentioned before and after 24 h incubation, the cultures were streaked onto Mueller 
Hinton agar surface (Difco, Michigan, USA) previously supplemented with 5% (v/v) sheep blood (Ebefarma, Rio 
de Janeiro, Brazil). The plates were incubated at 37 °C under anaerobic condition and after 24 h, they were exan-
imated for signs of β-hemolysis (clear zones around colonies), α-hemolysis (green-hued zones around colonies) 
or γ-hemolysis (no zones around colonies)49.
Antibiotic susceptibility. Antibiotic susceptibility was determined by the modified Kirby-Bauer disc diffusion 
method52. Discs (all provided by Laborclin, São Paulo, Brazil) of the following antibiotics were used: ampicillin 
(10 μg); chloramphenicol (30 μg); clindamycin (2 μg); gentamicin (10 μg); streptomycin (10 μg); rifampicin (5 μg), 
and vancomycin (30 μg), all selected following the suggestion stated on the document Opinion of the Scientific 
Committee on Animal Nutrition on the criteria for assessing the safety of micro-organisms resistant to antibiotics of 
human clinical and veterinary importance53. Briefly, the isolates were cultured in the above-mentioned medium 
and conditions. After 24 h, the concentration of isolates’ cell suspension was adjusted according to 0.5 McFarland 
(Probac, São Paulo, Brazil) standard and spread over the surface of Mueller Hinton agar plates. When the sus-
pensions were dried, the discs were carefully placed onto the plates and anaerobically incubated at 37 °C for 24 h. 
Presence or absence of inhibition zones was defined as sensitivity or resistance, respectively, interpreted according 
to the cut-off levels proposed by Charteris et al.54.
Coexistence test. The compatibility among the selected isolated was performed according to Guo et al.55. The 
selected isolates were cultured in the appropriate conditions and after 24 h they were streaked perpendicularly 
and across each other on MRS 1.5% (w/v) agar plates. The plates were anaerobically incubated at 37 °C and after 
24 h antagonism or absence of was observed.
Cell surface hydrophobicity. The cell surface hydrophobicity assay was conducted according to García-Hernández 
et al.56. In this sense, the hydrophobicity was determined as the ability of the isolates to adhere to hydrocarbons 
(MATS: Microbial Adhesion to Solvents), using toluene as solvent. This assay was carried out culturing the iso-
lates in appropriated medium and temperature for 24 h. A 3 mL-aliquot from each culture broth were centrifu-
gated at 4.470 g at 4 °C for 10 min and the pellets were washed twice with PBS (pH 7.2) and resuspended in same 
buffer until achieve the concentration of 1.0 OD at 560 nm (Ab0). To three milliliter of these solutions, 0.6 mL of 
toluene (Synth, São Paulo, Brazil) was added and gently mixed for 2 min. After an incubation period of 1 h at 
37 °C, the aqueous phase (bottom phase) was carefully collected and the OD560 nm was determined again (Ab1). 











Isolates with MATS above 50% were considered as hydrophobic.
Bacterial adhesion to intestinal epithelial cells. The adhesion capacity of the isolates was investigated according to 
Jensen et al.57 with some modifications. Basically, 2.105 cells from human colon adenocarcinoma (Caco-2; ATCC 
HTB-37, Manassas VA, USA) were sub-cultivated in 24-well culture plates containing Dulbecco’s modified Eagle’s 
medium (DMEM; Vitrocell Embriolife, Campinas, Brazil) containing low glucose, and 20% (v/v) fetal bovine 
serum (Vitrocell Embriolife, Campinas, Brazil) and 100 U/ml penicillin/streptomycin (Sigma-Aldrich, St. Louis, 
USA). Then, the 24-well plates were incubated at 37 °C in a humidified atmosphere of 5% CO2 and 95% air until 
reach confluence growth (3 days). The assays were carried out, by culturing the bacterial isolates on MRS broth 
for 24 h at 37 °C, centrifugation (10.000 g for 10 min) and the resulting pellets were resuspended in DMSO without 
antibiotics supplementation. Before experiments, the Caco-2 monolayers were washed twice with PBS to remove 
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antibiotics from the original cell media and 1 mL of each bacterial cells solution (107 CFU/mL) were individually 
added to the wells. Subsequently, the well-plates were incubated at 37 °C for 1, 2 or 4 h in order to determine the 
best adhesion period. After that, the bacterial solutions were removed from each well and the monolayers were 
washed twice with PSB to remove non-adherent bacteria. Finally, the monolayers were lysed by addition of PBS 
added with 0.1% Triton-X100 (Sigma-Aldrich, St. Louis, USA). The resulting suspension with viable adhered 
bacteria were serially diluted and plated onto MRS agar by pour plate method. After 48 h incubation in anaero-
bic jar, the number of colony forming units per mL was counted. Bacterial adhesion capacity was expressed as a 
percentage, which was calculated using the ratio of the number of bacterial cells that remained attached in the 
monolayer to the total number of bacterial cells added initially to each well. The experiment was performed in 
biological triplicate.
Statistical analyses. The results were expressed as the mean and standard deviation (S.D.). The counts of 
viable bacteria were transformed to log values. The values in the tolerance test were compared by Student’s t-test. 
P-values less than 0.05 were regarded as a significant difference.
Results and discussion
evaluation of antimicrobial activities in LAB isolates. From the cecum content of broiler chickens, 
314 colonies were aleatory selected and their antimicrobial activity against S. Heidelberg IOC 969/17 were evalu-
ated. From these assays 35 isolates stood out compared to the others, producing large inhibition zones against the 
bioindicator strain (Fig. 1) and these were characterized as being Gram-positive with coccus- and rod-shaped, 
non-sporulating and catalase-negative, which are predominant features of the LAB group58.
The antimicrobial activity of pH neutralized samples (CFS-A) was evaluated against S. Heidelberg IOC 969/17 
and did not present any antimicrobial activity. Considering this result and the fact that BLIS antimicrobial activ-
ity is target-specific59, the samples were tested against other pathogens including L. monocytogenes CECT-934, 
S. enterica CECT-724, S. aureus CECT-237, E. coli ATCC 25922, C. piscicola CECT-4020 and L. innocua CLIST 
2052.
Interestingly, the highest antimicrobial activities were observed against Gram-positive species, especially S. 
aureus CECT-237 (see Table 1). None of the neutralized samples were capable of producing inhibition zones 
against S. enterica strain CECT-724 or E. coli ATCC 25922, both being Gram-negative. According to Prudêncio 
et al.60, bacteriocins produced by Gram-positive microorganisms are not effective against Gram-negative ones 
since the latter are resistant to their action. This occurs because Gram-negative bacteria have are very complex 
outer membrane that make them resistant to certain antibiotics, dyes, and detergents61. Certain treatments can 
alter this unique outer membrane and make it permeable and, consequently, making the bacterial cells sensitive 
to bacteriocins62. Particularly, Salmonella species have been frequently pre-exposed to chelating agents, for exam-
ple EDTA which acts by destabilizing the complex membrane of Gram-negative bacteria and cause the release 
its structural components or disrupt the lipopolysaccharide layer (LPS), allowing the bacteriocin to act60. In this 
sense, this strategy could be a useful alternative to overcome the Salmonella’s resistance to the BLIS produced by 
our isolates, being therefore a test that will be carried out in the future. Based on the results presented in Table 1, 
the isolates labeled as C43, C173 and C195 were chosen for further study.
The samples were treated with proteolytic enzymes and no inhibition zones was observed against S. aureus 
CECT-237, suggesting that the antimicrobial effect is provided by BLIS as suggested by previous works63–66.
Considering that neutralized samples from C43, C173 e C195 did not produced antimicrobial activities 
against Salmonella species, untreated samples (CFS-B) were evaluated against S. Heidelberg IOC 969/17. As 
can be observed in Fig. 2, all three samples demonstrated a satisfactory growth inhibition of S. Heidelberg IOC 
969/17, especially the CFS-B extracted from C173 and C195. These results suggest that the antimicrobial activity 
Figure 1. Inhibition zones against Salmonella Heidelberg IOC 969/17 produced by LAB colonies isolated from 
chicken cecum content.













C12 — 13.8 — —
C13 13.0 17.6 — 12.3
C14 15.9 17.7 23.1 12.3
C15 12.6 8.7 15.5 12.4
C18 11.9 15.9 16.2 11.9
C19 12.5 14.8 — 13.1
C22 11.2 — — 11.0
C23 11.1 16.9 22.4 12.1
C25 — 15.5 — —
C26 10.8 — — 10.6
C28 12.6 16.3 15.1 12.9
C34 — — — —
C35 — 14.2 — —
C43 12.5 18.9 23.3 14.1
C45 11.4 16.2 — 11.6
C52 10.9 15.7 — 11.8
C78 — 14.9 — —
C79 10.3 — — 11.7
C81 12.8 18.3 24.3 —
C83 16.0 17.9 23.4 12.8
C127 — — — —
C129 — — — —
C138 — 13.8 — —
C147 — 15.8 — —
C149 — 13.8 — —
C150 — 14.3 — 10.2
C154 — 16.5 — 10.7
C155 10.6 — — 10.9
C165 — — — 8.6
C169 13.3 16.4 19.0 —
C171 15.7 17.0 22.4 —
C173 17.3 21.5 20.8 13.9
C195 16.4 19.5 21.3 13.9
C197 16.5 18.9 24.3 15.3
C206 14.6 16.7 20.7 12.9
Table 1. Antimicrobial activity of CFS-A extracted from the culture of the isolates against bioindicator strains. 

















Figure 2. Antimicrobial activity of CFS-B extracted from culture broth of C43 (gray markers); C173 (blue 
markers); and C195 (orange markers) against Salmonella Heidelberg IOC 969/17 (yellow markers). Error bars 
correspond to standard deviations over three replicates.
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produced by C43, C173 and C195 isolates against S. Heidelberg IOC 969/17 is not provided by BLIS, but by 
organic acids produced during their growth. When the culture media without bacterial growth was used as a 
control, S. Heidelberg inhibition was not observed (data not shown).
The use of such substances to combat Salmonella species in poultry products or products is very well doc-
umented67–70. The antimicrobial activity of organic acids can be explained because these substances can pass 
through the membranes of the target cells which will be dissociated in the more alkaline interior, acidifying the 
cell cytoplasm70. Many authors have shown that organic acids produced by probiotic LAB have antimicrobial 
effects and can be used as feed additive71–74. Furthermore, it has been shown that LAB can produce short and 
medium chain fatty acids (SCFA and MCFA) and other metabolites in the gastrointestinal tract of poulty that 
possess antagonism properties67 against different Salmonella species and on other microorganisms found in the 
avian microbiome67,70,73. Our results concur with these previous studies and suggest that our isolates could be 
useful to be used as supplements for poultry feed.
Screening for vitamin producing isolates. In poultry nutrition, the deficiency of B-complex vitamins, 
especially riboflavin and folates can directly affect the health and well-being of birds.
Riboflavin are present in numerous co-enzymes that are involved in oxidation-reduction reactions for cell 
respiration75. When there is riboflavin deficiency in poultry, their growth is reduced caused by the loss of appetite 
and the appearance of diarrhea is very common75. Frequently, riboflavin deficient chicks cannot walk due to leg 
or curled-toe paralysis76. In addition, riboflavin deficiency in hens has been shown to lower egg production, cause 
the death of embryos, and increase the fat content in their livers75,77.
Folate also acts as a co- enzyme by accepting or donating single-carbon in amino acids and nucleic acids 
synthesis31. This vitamin is essential for purine and methyl groups synthesis which is why folates are essential for 
cell multiplication75. Folate deficiencies can reduce growth, cause megaloblastic anemia, produce poor feathering, 
achromat of feathers in colored poultry, and chondrodystrophy31,75.
Riboflavin and folate producing LAB can be an interesting option to supplement the diets of animal diets 
since they could release the vitamin in their feed or produce these essential nutrients in the gastrointestinal tract 
(although it is still unknown how much vitamins can be produce in situ).
In our study, among the 35 isolates selected in the previously step, those displaying the largest inhibition zones 
against the bioindicator strains were used to study their ability to produce folates and/or riboflavin. Eight isolates 
were selected, as means C43, C81, C83, C173, C195, C197 and C206. Posteriorly, these isolates were cultured in 
media culture broths free from folic acid and riboflavin and after 7 subcultures, from 8 isolates, 3 of them (C43, 
C173, and C195) grew well in the riboflavin free-culture medium and 5 isolates (C43, C81, C83, C173 C195) 
presented a good growth in the folic acid free-culture medium. Three of these 8 isolates (C43, C173, and C195) 
showed good growth in both culture media, suggesting riboflavin and folates are produced simultaneously.
As can be observed in Table 2, the isolates C195 and C173 showed the higher folate production (595 and 58 ng/
mL respectively).
The total riboflavin production by the 3 isolates are similarly, resulting in 230.0 ng/L (±0.04) by C43; 
223.3 ng/L (±0.02) by C173; and 175.0 ng/mL (±0.04) by C195.
Many researchers stated the folate and riboflavin production by lactic acid bacteria30,78–81, but few have already 
reported the simultaneous production of both B-complex vitamins by a single strain, which represents an impor-
tant advantages of our findings, especially for the poultry industries, since the LAB producing B-complex vita-
mins are mainly focused in human consumptions, instead of animals nutrition82.
According to the document published by National Research Council in 1994, the daily intake requirement 
of folic acid and riboflavin is about 1 and 5 mg per kg of diet, respectively83. The daily feed consumption varies 
considerably between gender and also the poultry specification, i.e. laying hens and broiler chicken, for examples. 
For broiler chicken, a 1-day old male chicken consumes about 13 g of feed84. When the same chicken reaches 45 
days of life, its daily consumption is of approximately 186 g of feed. The same estimative can be done about water 
intake. A 1-week broiler chicken can drinks about 40 mL of water per day, which increase 5 times when this 
chicken is 3-weeks old84.
Feed for poultry are formulated to make sure that they contain more than enough micronutrients (vitamins 
and minerals) to avoid deficiencies and take into account the amounts that are lost during their processing, 
storage and transport75. In fact, this is sometimes questioned as being too costly84. Thus, including our isolates 
in commercial poultry nutrition can be an economic alternative. Another advantage is associated to the fact that 
they could be more stable to storage conditions, one of the major causes of loss of vitamins bioavailability75.






Table 2. Total folic acid concentration produced by the isolates selected on the step of screening of acid folic 
LAB producers. Error bars correspond to standard deviations over three replicates.
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Identification of the selected isolates by MALDI-TOFMS Biotyper. Considering the best perfor-
mance of the isolates C43, C173 and C195, the genus and species of such microorganisms were identified by 
MALDI-TOFMS Biotyper that identifies microorganisms by using protein profiles of microorganisms and com-
parison with known patterns47,85. This technique is fast, economic and is a reliable alternative to conventional 16 s 
rRNA PCR amplification and sequencing to identify microorganisms85,86.
The isolate C43 was identified as E. faecium, whereas C173 and C195 were both identified as being strains of 
L. lactis subsp. lactis.
The presence and the isolation of E. faecium from chicken microbiota is very well documented in the litera-
ture87–89, but this is not the case for L. lactis strains. This species is normally found in dairy, vegetable, sausages, 
raw pork, vacuum-packed seafood90 and from chicken cecum91.
According to the Food and Agriculture Organization92, both species have been used as probiotics in poultry 
diets. E. faecium has shown to be able to increased growth performance, improved intestinal morphology, and 
possess antagonism effects against important pathogens in poultry production93,94. Its usage in poultry nutri-
tion is so widely defunded that are many commercial feed composed with E. faecium, for example PoultryStar®, 
Protexin®, and Biomin92.
Although the use of L. lactis in poultry is not very common, Maiorano et al.95 demonstrated increased feed 
conversion ratio (FCR) when a symbiotic mixture of L. lactis ssp. cremoris IBB SC1 and raffinose were injected 
in chickens’ eggs in order to evaluate its effect on productivity, the quality of the meat produced, and on the 
incidence of pectoral muscle pathologies in broiler chickens. On the other hand, Pruszynska-Oszmalek et al.96 
reported that of L. lactis subsp. lactis added with a prebiotic mixture of galacto-oligosaccharide and inulin did not 
result in improved FCR, but significantly increased final body weight of the chickens tested. Another interesting 
approach is a lactococcal vaccine proposed by Reese and collaborators97. In this study, the author demonstrated 
the protected effect of the vaccinated birds against the avian influenza virus.
As can be observed, both species, i.e. E. faecium and L. lactis subsp. lactis have being proven their benefits to 
chickens health when administrated as probiotic bacteria.
evaluating the probiotic potential of the selected isolates. In order for orally ingested bacteria to be 
able to exert a beneficial effect on their host, they must survive the passage through the stomach and the presence 
of bile salts in the intestinal lumen and arrive alive in the large intestines98. As can be observed in Fig. 3, except 
the C43, the isolates C173 and C195 showed significantly loss of viability in low pH conditions; however, their 
encapsulation or addition in a food matrix could increase their survival50.
Although bovine bile is normally used to evaluate the tolerance of bacteria, bile salts from pork are more sim-
ilar to that produced by humans99, justifying its using in the present study.
Overall, bile salts at 0.5% concentration did not affect the survival of the isolates C43, C173 and C195 (Fig. 4)
Bile salt concentrations are crucial as a defense mechanisms by inhibiting the survival of microorganisms100. 
The resistance to bile salts is this critical for probiotic strains selection in order for them to arrive in a live form 
after its passage in the small intetines49.
Hemolytic activity and antibiotic resistance. None of the selected isolates demonstrated β or α-hemolytic activi-
ties, essential for the possible use of the strains101.
Because of the increasing problems concerning antibiotic resistance, it is important that probiotics that are to 
be used in poultry feed additive not be reservoirs for antibiotic resistance genes102,103.
According to zones diameters breakpoints established by Charteris et al.54, all isolates were sensitive to the 
studied antibiotics except for L. lactis subsp. lactis C173, which showed resistant to vancomycin. This result is 
similar to those of other studies50,82,98. Although it was previously reported certain strains of L. casei, L. rhamno-
sus, L. plantarum, pediococci and Leuconostoc spp. are resistant to vancomycin, this property is of much concern 
because this antibiotic is is one of the last antibiotics that is useful in infections caused by multidrug-resistant 
pathogens104,105. Based in the study reported by Temmerman et al.106, it would be appropriate to use other meth-
ods to confirm the presence of vancomycin resistance in L. lactis subsp. lactis C173, like Minimal Inhibitory 
















Figure 3. Viability of the isolates C43 (gray bars), C173 (blue bars), and C195 (orange bars) after 0, 0.5, 1, 2, and 
3 h incubation under low pH (2.5). Error bars correspond to standard deviations over three replicates.
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Coexistence test. With the aim of obtaining multi-strain probiotics, and due to their antimicrobial properties, 
strain compatibility must be evaluated107.
As can be observed in Fig. 5, the isolate L. lactis subsp. lactis C173 and L. lactis subsp. lactis C195 reveled their 
antagonistic effect against E. faecium C43. Based on this data and assuming that this effect could also occur in 
vivo, the E. faecium C43 were excluded from the following tests.
Hydrophobicity property and adhesion of the selected isolates to Caco-2 cells. In order to evaluate their potential 
action in the gastrointestinal tract, adhesion to human colon carcinoma and the evaluation of hydrophobicity 
must be performed107. Hydrophobicity has been associated with bacterial adhesion properties108 reason for which 
the isolates’ adhesion to toluene was measured. The L. lactis subsp. lactis C173 showed a moderate hydrophobicity 
(44%), while L. lactis subsp. lactis C195 hydrophilic surface (9.2%).
Adherence to Caco-2 assay showed that both isolates presented high value of adhesion to this cells (Fig. 6). 
For L. lactis subsp. lactis C173, after 1, 2 and 4 h incubation, the bacterial solution presented values of adhesion 
of 13.2, 27.9 and 35.6%, respectively. L. lactis subsp. lactis C195 in turn, resulted in adhesion values of 7.3, 20.3 
and 46.3% after 1, 2 and 4 h incubation, respectively. According to Gharbi et al.98, Laiño et al.109 and Jensen et al.57  















Figure 4. Survival of the isolates C43 (gray bars), C173 (blue bars), and C195 (orange bars) after exposition 
0.5% bile salts for 0, 0.5, 1, 2, and 3 h incubation. Error bars correspond to standard deviations over three 
replicates.
Figure 5. Isolates compatibility demonstrated by coexistence test. The cross-streaked assay reveled the 
antagonism effect of Lactococcus lactis subsp. lactis C173 (Lines 2) and Lactococcus lactis subsp. lactis C195 
(Lines 3) against Enterococcus faecium C43 (Lines 1). The intersection between the lines 1 and 3 is extended in 
the figure inset.
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incubation results higher adhesion percentages, but independently of this incubation time, both cells showed 
strong adhesion with Caco-2 cells. This high adhesion percentage suggests that these strains are likely to colonize 
the GI tract. It is important that probiotics adhere to the intestinal epithelium in order to facilitate their coloniza-
tion and prevent pathogen binding110.
As mentioned before, bacterial cell hydrophobicity is frequently associated to the adherence to the human 
epithelium cells; however there is conflicting reports on this direct association98,111. Our findings are in agreement 
with these latter authors that there is no direct association between hydrophobicity and the binding habilities of 
our isolates.
conclusion
From 314 isolates from chicken cecum, the isolates labeled as C43, C175 and C195 demonstrated antagonistic 
effect towards many pathogens. Using proteolytic enzymes, it was demonstrated that the antimicrobial effect 
against Listeria species, C. piscicola and S. aureus was caused by BLIS and by organic acids against S. Heridelberg. 
The isolates, identified as E. faecium and L lactis subsp. lactis, also produced the B-complex vitamins folate and 
riboflavin, which is very interesting considering the diseases related to the lack of these nutrients in the feeding of 
birds. After in vitro probiotic assays, the L. lactis subsp. lactis strains C173 and C195 demonstrated high potential 
to be used as probiotic in poultry feed being a useful alternative to replace antibiotics in poultry husbandry. In 
order to demonstrate this potential, in-vivo trials will be required and are currently underway.
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